Sanofi-Aventis and Regeneron expand antibody partnership
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis and Regeneron Pharmaceuticals are expanding their pact in the field of antibodies, increasing its term and the annual payments that Sanofi-Aventis will make to its partner.